Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Japan Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20141
20151
20173
20181
20191
20203
20222
20233
20244
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting7
Active, not recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim9
Celgene4
GlaxoSmithKline3
AstraZeneca2
Bristol-Myers Squibb2
Insmed Incorporated2
Astellas Pharma Inc1
Novartis Pharmaceuticals1
Pulmovant, Inc.1
Tokyo Medical and Dental University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial27
Arrhythmias, Cardiac4
Heart Failure4
Hypersensitivity4
Infections4
Peripheral Nervous System Diseases4
Scleroderma, Diffuse4
Teratogenesis4
Tumor Lysis Syndrome4
Connective Tissue Diseases3

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.